Literature DB >> 18373416

Stressful life events and adherence in HIV.

Jane Leserman1, Gail Ironson, Conall O'Cleirigh, Joanne M Fordiani, Elizabeth Balbin.   

Abstract

Because medication adherence is critical to improving the virologic and immunologic response to therapy and reducing the risk of drug resistance, it is important that we understand the predictors of nonadherence. The goal of the current study is to examine demographic, health behavior and psychosocial correlates (e.g., stressful life events, depressive symptoms) of nonadherence among a sample of HIV infected men and women from one south Florida metropolitan area. We collected questionnaire data from on 105 HIV infected men and women who were taking antiretroviral medication during the years 2004 to 2007. In this sample, 44.8% had missed a medication dose in the past 2 weeks, and 22.1% had missed their medication during the previous weekend. Those with three or more stressful life events in the previous 6 months were 2.5 to more than 3 times as likely to be nonadherent (in the past 2 weeks and previous weekend, respectively) compared to those without such events. Fully 86.7% of those with six or more stresses were nonadherent during the prior 2 weeks compared to 22.2% of those with no stressors. Although alcohol consumption, drug use, and symptoms of depression were related to nonadherence in the bivariate analyses, the effects of these predictors were reduced to nonsignificance by the stressful event measure. These findings underscore the importance of addressing the often chaotic and stressful lives of HIV infected persons within medical settings.

Entities:  

Mesh:

Year:  2008        PMID: 18373416      PMCID: PMC2567910          DOI: 10.1089/apc.2007.0175

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  35 in total

1.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Authors:  Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

Authors:  D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

Review 3.  HIV disease progression: depression, stress, and possible mechanisms.

Authors:  Jane Leserman
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

4.  Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection.

Authors:  Joan S Tucker; M Audrey Burnam; Cathy D Sherbourne; Fuan-Yue Kung; Allen L Gifford
Journal:  Am J Med       Date:  2003-05       Impact factor: 4.965

5.  Relation of lifetime trauma and depressive symptoms to mortality in HIV.

Authors:  Jane Leserman; Brian Wells Pence; Kathryn Whetten; Michael J Mugavero; Nathan M Thielman; Marvin S Swartz; Dalene Stangl
Journal:  Am J Psychiatry       Date:  2007-11       Impact factor: 18.112

6.  Nonadherence among HIV-infected injecting drug users: the impact of social instability.

Authors:  Anne-Déborah Bouhnik; Margaret Chesney; Patrizia Carrieri; Hervé Gallais; Jacques Moreau; Jean-Paul Moatti; Yolande Obadia; Bruno Spire
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

Review 7.  Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

Authors:  Fabrizio Starace; Adriana Ammassari; Maria Paola Trotta; Rita Murri; Patrizio De Longis; Crescenzo Izzo; Alfredo Scalzini; Antonella d'Arminio Monforte; Albert W Wu; Andrea Antinori
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

8.  A prospective study of predictors of adherence to combination antiretroviral medication.

Authors:  Carol E Golin; Honghu Liu; Ron D Hays; Loren G Miller; C Keith Beck; Jeanette Ickovics; Andrew H Kaplan; Neil S Wenger
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

9.  Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors.

Authors:  J Leserman; J M Petitto; H Gu; B N Gaynes; J Barroso; R N Golden; D O Perkins; J D Folds; D L Evans
Journal:  Psychol Med       Date:  2002-08       Impact factor: 7.723

10.  Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.

Authors:  Bruno Spire; Ségolène Duran; Marc Souville; Catherine Leport; François Raffi; Jean-Paul Moatti
Journal:  Soc Sci Med       Date:  2002-05       Impact factor: 4.634

View more
  59 in total

1.  Mediators of antiretroviral adherence: a multisite international study.

Authors:  I B Corless; A J Guarino; P K Nicholas; L Tyer-Viola; K Kirksey; J Brion; C Dawson Rose; L S Eller; M Rivero-Mendez; J Kemppainen; K Nokes; E Sefcik; J Voss; D Wantland; M O Johnson; J C Phillips; A Webel; S Iipinge; C Portillo; W-T Chen; M Maryland; M J Hamilton; P Reid; D Hickey; W L Holzemer; K M Sullivan
Journal:  AIDS Care       Date:  2012-07-09

2.  Childhood sexual abuse and depression in Latino men who have sex with men: Does resilience protect against nonadherence to antiretroviral therapy?

Authors:  John A Sauceda; John S Wiebe; Jane M Simoni
Journal:  J Health Psychol       Date:  2014-08-25

3.  Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV.

Authors:  Nancy A Hessol; Susan Holman; Howard Minkoff; Mardge H Cohen; Elizabeth T Golub; Seble Kassaye; Roksana Karim; Oluwakemi Sosanya; Christopher Shaheen; Zaher Merhi
Journal:  AIDS Care       Date:  2015-08-14

4.  Medication adherence in people dually treated for HIV infection and mental health conditions: test of the medications beliefs framework.

Authors:  Seth C Kalichman; Jennifer Pellowski; Christopher Kegler; Chauncey Cherry; Moira O Kalichman
Journal:  J Behav Med       Date:  2015-04-03

5.  Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals.

Authors:  Timothy J Arentsen; Stella Panos; April D Thames; J Natalie Arbid; Steven A Castellon; Charles H Hinkin
Journal:  J HIV AIDS Soc Serv       Date:  2016-09-23

6.  Life events, coping, and antihypertensive medication adherence among older adults: the cohort study of medication adherence among older adults.

Authors:  Elizabeth W Holt; Paul Muntner; C Joyce; Donald E Morisky; Larry S Webber; Marie Krousel-Wood
Journal:  Am J Epidemiol       Date:  2012-10-01       Impact factor: 4.897

Review 7.  Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011.

Authors:  Cathy M Puskas; Jamie I Forrest; Surita Parashar; Kate A Salters; Angela M Cescon; Angela Kaida; Cari L Miller; David R Bangsberg; Robert S Hogg
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

8.  The Role of Chronic Psychosocial Stress in Explaining Racial Differences in Stress Reactivity and Pain Sensitivity.

Authors:  Jennifer L Gordon; Jacqueline Johnson; Samantha Nau; Beth Mechlin; Susan S Girdler
Journal:  Psychosom Med       Date:  2017 Feb/Mar       Impact factor: 4.312

9.  Gender-specific effects of an augmented written emotional disclosure intervention on posttraumatic, depressive, and HIV-disease-related outcomes: a randomized, controlled trial.

Authors:  Gail Ironson; Conall O'Cleirigh; Jane Leserman; Rick Stuetzle; Joanne Fordiani; MaryAnn Fletcher; Neil Schneiderman
Journal:  J Consult Clin Psychol       Date:  2012-12-17

10.  Relationship between trauma and high-risk behavior among HIV-positive men who do not have sex with men (MDSM).

Authors:  Kathryn Whetten; Susan Reif; Matthew Toth; Erica Jain; Jane Leserman; Brian W Pence
Journal:  AIDS Care       Date:  2012-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.